Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists

Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists

Hamish Courtney,1 Rahul Nayar,2 Chinnadorai Rajeswaran,3 Ravi Jandhyala 4 1Diabetes Department, Royal Victoria Hospital, Belfast, 2City Hospitals Sunderland NHS Foundation Trust, Sunderland, 3Department of Diabetes & Endocrinology, Mid Yorkshire NHS Trust, Dewsbury, 4Medical Affairs, Diabete...

Full description

Bibliographic Details
Main Authors: Courtney H, Nayar R, Rajeswaran C, Jandhyala R
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
albiglutide
dulaglutide
exenatide
liraglutide
lixisenatide
long-term
Online Access:https://www.dovepress.com/long-term-management-of-type-2-diabetes-with-glucagon-like-peptide-1-r-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/long-term-management-of-type-2-diabetes-with-glucagon-like-peptide-1-r-peer-reviewed-article-DMSO

Similar Items